We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$86.1B
AUM Growth
+$2.33B
(+2.8%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
1,869
New
68
Increased
904
Reduced
795
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$325M |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$319M |
| 3 |
Williams Companies
WMB
|
+$313M |
| 4 |
TGE
Tallgrass Energy, LP Class A Shares
TGE
|
+$303M |
| 5 |
Pinduoduo
PDD
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$937M |
| 2 |
AET
Aetna Inc
AET
|
+$561M |
| 3 |
WPZ
Williams Partners L.P.
WPZ
|
+$296M |
| 4 |
JD.com
JD
|
+$295M |
| 5 |
TEP
Tallgrass Energy Partners, LP
TEP
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.01% |
| 2 | Healthcare | 14.62% |
| 3 | Consumer Discretionary | 14.06% |
| 4 | Financials | 13.33% |
| 5 | Energy | 12.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Canadian Pacific Kansas City
CP
$81.1B
| $16.9M | 0.02% |
398,050
-370,200
| -48% | -$14.8M |
|
627
GSK
GSK
$104B
| $16.8M | 0.02% |
+333,846
| New | +$17M |
|
628
Las Vegas Sands
LVS
$31.6B
| $16.7M | 0.02% |
282,026
-918,837
| -77% | -$61.7M |
|
629
Supernus Pharmaceuticals
SUPN
$2.73B
| $16.7M | 0.02% |
331,809
+26,407
| +9% | +$1.3M |
|
630
CenterPoint Energy
CNP
$28.8B
| $16.7M | 0.02% |
604,075
+571,156
| +1,735% | +$16M |
|
631
Packaging Corp of America
PKG
$22.5B
| $16.7M | 0.02% |
152,200
-229,198
| -60% | -$25.8M |
|
|
HMHC
632
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $16.6M | 0.02% |
2,377,602
+366,760
| +18% | +$2.47M |
|
633
Lennar Class A
LEN
$20.5B
| $16.6M | 0.02% |
366,949
-31,547
| -8% | -$1.59M |
|
|
KYNB
634
Kyntra Bio
KYNB
$28.5M
| $16.5M | 0.02% |
10,874
-3,350
| -24% | -$5.16M |
|
|
NBLX
635
DELISTED
Noble Midstream Partners LP
NBLX
| $16.5M | 0.02% |
464,581
+73,467
| +19% | +$3.42M |
|
|
MINI
636
DELISTED
Mobile Mini Inc
MINI
| $16.4M | 0.02% |
373,976
+35,668
| +11% | +$1.58M |
|
|
EVBG
637
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $16.3M | 0.02% |
+282,862
| New | +$15.3M |
|
|
VISN
638
Vistance Networks Inc
VISN
$2.67B
| $16.2M | 0.02% |
526,835
-1,111
| -0.2% | -$34.1K |
|
639
Allstate
ALL
$67.3B
| $16.1M | 0.02% |
163,163
-93,629
| -36% | -$9.13M |
|
640
Rigel Pharmaceuticals
RIGL
$692M
| $16.1M | 0.02% |
500,000
| – | – |
|
|
CMD
641
DELISTED
Cantel Medical Corporation
CMD
| $16M | 0.02% |
173,535
-241,775
| -58% | -$23M |
|
642
Delek Logistics
DKL
$3.03B
| $15.7M | 0.02% |
460,343
| – | – |
|
643
Becton Dickinson
BDX
$43.8B
| $15.5M | 0.02% |
60,898
-4,872
| -7% | -$1.2M |
|
644
SL Green Realty
SLG
$3.83B
| $15.5M | 0.02% |
+164,116
| New | +$16.2M |
|
645
Columbia Banking Systems
COLB
$8.74B
| $15.4M | 0.02% |
396,294
+20,863
| +6% | +$866K |
|
646
Cencora
COR
$60.5B
| $15.3M | 0.02% |
166,117
+11,881
| +8% | +$1.03M |
|
|
PFPT
647
DELISTED
Proofpoint, Inc.
PFPT
| $15.2M | 0.02% |
143,239
-140,160
| -49% | -$16.3M |
|
|
BLD
648
DELISTED
TopBuild
BLD
| $15.2M | 0.02% |
267,618
-246,521
| -48% | -$17.6M |
|
649
Addus HomeCare
ADUS
$2.16B
| $15.1M | 0.02% |
215,003
-9,076
| -4% | -$588K |
|
650
Wheaton Precious Metals
WPM
$50.9B
| $15M | 0.02% |
859,906
+84,253
| +11% | +$1.62M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2018 Portfolio in Review
As of Q3 2018, OppenheimerFunds held 1,869 positions worth $86.1B, up 2.8% from $83.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q3 2018 filing shows 68 new, 904 increased, 795 reduced and 59 closed positions. Its largest new stake was Pinduoduo: 13,524,290 shares worth $356M. The largest sale was Trip.com Group, an estimated $937M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- OppenheimerFunds's largest Q3 2018 buy was Pinduoduo: 13,524,290 shares worth $356M.
- OppenheimerFunds added most to Prologis in Q3 2018, an estimated $325M increase.
- OppenheimerFunds's biggest Q3 2018 reduction was Aetna Inc, cutting an estimated $561M.
- OppenheimerFunds fully exited Trip.com Group in Q3 2018, selling an estimated $937M.
- OppenheimerFunds's ten largest holdings make up 16% of its $86.1B portfolio in Q3 2018.
- OppenheimerFunds opened 68 new positions and closed 59 in Q3 2018.
- OppenheimerFunds's portfolio value rose 2.8% quarter-over-quarter to $86.1B.
Based on OppenheimerFunds's 13F filing for Q3 2018, filed 13 Nov 2018.